Preplanned Safety Analysis Of The Jfmc37-0801 Trial: A Randomized Phase Iii Study Of Six Months Versus Twelve Months Of Capecitabine As Adjuvant Chemotherapy For Stage Iii Colon Cancer (Vol 22, Pg 494, 2017)